Global Pharmacovigilance and Drug Safety Software Market size is expected to reach US $ 274.5 Mn. by 2029, at a CAGR of 5.42% during the forecast period.To know about the Research Methodology :- Request Free Sample Report Global Pharmacovigilance and Drug Safety Software Market size by value is estimated and forecasted with the revenues of leading companies operating in the Global market with key developments in companies and market trends. Maximize Market Research offers high-quality market research reports, publishing around 1000 studies annually. These reports are custom made for a host of industries, providing in-depth market analysis and forecast, investigating significant business trends and highlighting and identifying possible development opportunities across the entire value chain. Teams of experienced and consummate research professionals constantly track important industries, recognizing key developments, potential growth opportunities and unmet needs. Our research reports are aimed to provide an in-depth understanding of the business environment, breaking down the market in a systematic process to highlight focus areas for clients.
Pharmacovigilance and Drug Safety Software Market Scope : Inquire Before Buying
Global Pharmacovigilance and Drug Safety Software Market Base Year 2022 Forecast Period 2023-2029 Historical Data CAGR Market Size in 2022 Market Size in 2029 2018 to 2022 5.42% US$ 189.7 Mn US$ 274.5 Mn Segments Covered by Functionality Adverse Event Reporting Software Drug Safety Audits Software Issue Tracking Software Fully Integrated Software by Delivery Model On-Premises On-Demand/Cloud Based by End User Pharma and Biotech Companies Contract Research Organizations (CROS) Business Process Outsourcing (BPO) Firms Other Pharmacovigilance Service Providers Regions Covered North America United States Canada Mexico Europe UK France Germany Italy Spain Sweden Austria Rest of Europe Asia Pacific China S Korea Japan India Australia Indonesia Malaysia Vietnam Taiwan Bangladesh Pakistan Rest of APAC Middle East and Africa South Africa GCC Egypt Nigeria Rest of ME&A South America Brazil Argentina Rest of South America Key Players :
1. IQVIA 2. Accenture 3. Cognizant 4. Laboratory Corporation of America Holdings 5. IBM 6. ArisGlobal 7. ICON Plc. 8. Capgemini 9. Oracle 10. Parexel International Corporation Frequently Asked questions 1. What is the market size of the Global market in 2022? Ans. The market size Global market in 2022 was US$ 189.7 Million. 2. What are the different segments of the Global market ? Ans. The Global market is divided into Functionality, Delivery Model and End User. 3. What is the study period of this market? Ans. The Global market will be studied from 2022 to 2029. 4. Which region is expected to hold the highest Global market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Pharmacovigilance and Drug Safety Software Market ? Ans. The Forecast Period of the market is 2023-2029 in the market.
Global Pharmacovigilance and Drug Safety Software Market
1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 1.4. Key Questions Answered 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations Used 2.3. Research Methodology 3. Executive Summary 3.1. Global Pharmacovigilance and Drug Safety Software Market Size, by Market Value (US$ Mn) and Market, by Region 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.3. Drivers and Restraints Snapshot Analysis 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.3.4. Porter’s Analysis 4.3.5. Value Chain Analysis 4.3.6. SWOT Analysis 5. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast 5.1. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast 5.2. Global Pharmacovigilance and Drug Safety Software Market Size& Y-o-Y Growth Analysis 5.2.1. North America 5.2.2. Europe 5.2.3. Asia Pacific 5.2.4. Middle East & Africa 5.2.5. Latin America 6. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by Functionality 6.1. Introduction and Definition 6.2. Key Findings 6.3. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 6.4. Market Size (US$ Mn) Forecast, by Functionality 6.5. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Functionality 6.6. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Functionality 7. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by Delivery Model 7.1. Introduction and Definition 7.2. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 7.3. Market Size (US$ Mn) Forecast, by Delivery Model 7.4. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Delivery Model 7.5. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Delivery Model 8. Global Pharmacovigilance and Drug Safety Software Market Analysis and Forecast, by End-User 8.1. Introduction and Definition 8.2. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 8.3. Market Size (US$ Mn) Forecast, by End-User 8.4. Global Pharmacovigilance and Drug Safety Software Market Analysis, by End-User 8.5. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by End-User 9. Global Pharmacovigilance and Drug Safety Software Market Analysis, by Region 9.1. Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Region 9.2. Market Size (US$ Mn) Forecast, by Region 9.3. Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis, by Region 10. North America Global Pharmacovigilance and Drug Safety Software Market Analysis 10.1. Key Findings 10.2. North America Global Pharmacovigilance and Drug Safety Software Market Overview 10.3. North America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 10.4. North America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 10.4.1. Adverse Event Reporting Software 10.4.2. Drug Safety Audits Software 10.4.3. Issue Tracking Software 10.4.4. Fully Integrated Software 10.5. North America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 10.6. North America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 10.6.1. On-Premises 10.6.2. On-Demand/Cloud Based 10.7. North America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 10.8. North America Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 10.8.1. Pharma and Biotech Companies 10.8.2. Contract Research Organizations (CROS) 10.8.3. Business Process Outsourcing (BPO) Firms 10.8.4. Other Pharmacovigilance Service Providers 10.9. North America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 10.10. North America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Country 10.10.1.1. U.S., 2018–2026 10.10.1.2. Canada, 2018–2026 10.11. North America Global Pharmacovigilance and Drug Safety Software Market Analysis, by Country 10.12. U.S. Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 10.12.1. Adverse Event Reporting Software 10.12.2. Drug Safety Audits Software 10.12.3. Issue Tracking Software 10.12.4. Fully Integrated Software 10.13. U.S. Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 10.13.1. On-Premises 10.13.2. On-Demand/Cloud Based 10.14. U.S. Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 10.14.1. Pharma and Biotech Companies 10.14.2. Contract Research Organizations (CROS) 10.14.3. Business Process Outsourcing (BPO) Firms 10.14.4. Other Pharmacovigilance Service Providers 10.15. Canada Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 10.15.1. Adverse Event Reporting Software 10.15.2. Drug Safety Audits Software 10.15.3. Issue Tracking Software 10.15.4. Fully Integrated Software 10.16. Canada Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 10.16.1. On-Premises 10.16.2. On-Demand/Cloud Based 10.17. Canada Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 10.17.1. Pharma and Biotech Companies 10.17.2. Contract Research Organizations (CROS) 10.17.3. Business Process Outsourcing (BPO) Firms 10.17.4. Other Pharmacovigilance Service Providers 10.18. North America Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 10.18.1. By Functionality 10.18.2. By Delivery Model 10.18.3. By End-User 10.19. PEST Analysis 11. Europe Global Pharmacovigilance and Drug Safety Software Market Analysis 11.1. Key Findings 11.2. Europe Global Pharmacovigilance and Drug Safety Software Market Overview 11.3. Europe Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 11.4. Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.4.1. Adverse Event Reporting Software 11.4.2. Drug Safety Audits Software 11.4.3. Issue Tracking Software 11.4.4. Fully Integrated Software 11.5. Europe Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 11.6. Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.6.1. On-Premises 11.6.2. On-Demand/Cloud Based 11.7. Europe Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 11.8. Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.8.1. Pharma and Biotech Companies 11.8.2. Contract Research Organizations (CROS) 11.8.3. Business Process Outsourcing (BPO) Firms 11.8.4. Other Pharmacovigilance Service Providers 11.9. Europe Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 11.10. Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by Country 11.10.1.1. Germany 11.10.1.2. U.K. 11.10.1.3. France 11.10.1.4. Italy 11.10.1.5. Spain 11.10.1.6. Rest of Europe 11.11. Europe Global Pharmacovigilance and Drug Safety Software Market Analysis, by Country/ Sub-region 11.12. Germany Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.12.1. Adverse Event Reporting Software 11.12.2. Drug Safety Audits Software 11.12.3. Issue Tracking Software 11.12.4. Fully Integrated Software 11.13. Germany Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.13.1. On-Premises 11.13.2. On-Demand/Cloud Based 11.14. Germany Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.14.1. Pharma and Biotech Companies 11.14.2. Contract Research Organizations (CROS) 11.14.3. Business Process Outsourcing (BPO) Firms 11.14.4. Other Pharmacovigilance Service Providers 11.15. U.K. Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.15.1. Adverse Event Reporting Software 11.15.2. Drug Safety Audits Software 11.15.3. Issue Tracking Software 11.15.4. Fully Integrated Software 11.16. U.K. Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.16.1. On-Premises 11.16.2. On-Demand/Cloud Based 11.17. U.K. Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.17.1. Pharma and Biotech Companies 11.17.2. Contract Research Organizations (CROS) 11.17.3. Business Process Outsourcing (BPO) Firms 11.17.4. Other Pharmacovigilance Service Providers 11.18. France Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.18.1. Adverse Event Reporting Software 11.18.2. Drug Safety Audits Software 11.18.3. Issue Tracking Software 11.18.4. Fully Integrated Software 11.19. France Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.19.1. On-Premises 11.19.2. On-Demand/Cloud Based 11.20. France Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.20.1. Pharma and Biotech Companies 11.20.2. Contract Research Organizations (CROS) 11.20.3. Business Process Outsourcing (BPO) Firms 11.20.4. Other Pharmacovigilance Service Providers 11.21. Italy Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.21.1. Adverse Event Reporting Software 11.21.2. Drug Safety Audits Software 11.21.3. Issue Tracking Software 11.21.4. Fully Integrated Software 11.22. Italy Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.22.1. On-Premises 11.22.2. On-Demand/Cloud Based 11.23. Italy Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.23.1. Pharma and Biotech Companies 11.23.2. Contract Research Organizations (CROS) 11.23.3. Business Process Outsourcing (BPO) Firms 11.23.4. Other Pharmacovigilance Service Providers 11.24. Spain Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.24.1. Adverse Event Reporting Software 11.24.2. Drug Safety Audits Software 11.24.3. Issue Tracking Software 11.24.4. Fully Integrated Software 11.25. Spain Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.25.1. On-Premises 11.25.2. On-Demand/Cloud Based 11.26. Spain Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.26.1. Pharma and Biotech Companies 11.26.2. Contract Research Organizations (CROS) 11.26.3. Business Process Outsourcing (BPO) Firms 11.26.4. Other Pharmacovigilance Service Providers 11.27. Rest of Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 11.27.1. Adverse Event Reporting Software 11.27.2. Drug Safety Audits Software 11.27.3. Issue Tracking Software 11.27.4. Fully Integrated Software 11.28. Rest of Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 11.28.1. On-Premises 11.28.2. On-Demand/Cloud Based 11.29. Rest of Europe Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 11.29.1. Pharma and Biotech Companies 11.29.2. Contract Research Organizations (CROS) 11.29.3. Business Process Outsourcing (BPO) Firms 11.29.4. Other Pharmacovigilance Service Providers 11.30. Europe Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 11.30.1. By Functionality 11.30.2. By Delivery Model 11.30.3. By End-User 11.31. PEST Analysis 12. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Analysis 12.1. Key Findings 12.2. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Overview 12.3. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 12.4. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.4.1. Adverse Event Reporting Software 12.4.2. Drug Safety Audits Software 12.4.3. Issue Tracking Software 12.4.4. Fully Integrated Software 12.5. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 12.6. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.6.1. On-Premises 12.6.2. On-Demand/Cloud Based 12.7. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 12.8. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.8.1. Pharma and Biotech Companies 12.8.2. Contract Research Organizations (CROS) 12.8.3. Business Process Outsourcing (BPO) Firms 12.8.4. Other Pharmacovigilance Service Providers 12.9. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 12.10. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by Country 12.10.1. China, 2018–2026 12.10.2. India, 2018–2026 12.10.3. Japan, 2018–2026 12.10.4. ASEAN, 2018–2026 12.10.5. Rest of Asia Pacific, 2018–2026 12.11. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Analysis, by Country/ Sub-region 12.12. China Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.12.1. Adverse Event Reporting Software 12.12.2. Drug Safety Audits Software 12.12.3. Issue Tracking Software 12.12.4. Fully Integrated Software 12.13. China Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.13.1. On-Premises 12.13.2. On-Demand/Cloud Based 12.14. China Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.14.1. Pharma and Biotech Companies 12.14.2. Contract Research Organizations (CROS) 12.14.3. Business Process Outsourcing (BPO) Firms 12.14.4. Other Pharmacovigilance Service Providers 12.15. India Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.15.1. Adverse Event Reporting Software 12.15.2. Drug Safety Audits Software 12.15.3. Issue Tracking Software 12.15.4. Fully Integrated Software 12.16. India Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.16.1. On-Premises 12.16.2. On-Demand/Cloud Based 12.17. India Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.17.1. Pharma and Biotech Companies 12.17.2. Contract Research Organizations (CROS) 12.17.3. Business Process Outsourcing (BPO) Firms 12.17.4. Other Pharmacovigilance Service Providers 12.18. Japan Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.18.1. Adverse Event Reporting Software 12.18.2. Drug Safety Audits Software 12.18.3. Issue Tracking Software 12.18.4. Fully Integrated Software 12.19. Japan Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.19.1. On-Premises 12.19.2. On-Demand/Cloud Based 12.20. Japan Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.20.1. Pharma and Biotech Companies 12.20.2. Contract Research Organizations (CROS) 12.20.3. Business Process Outsourcing (BPO) Firms 12.20.4. Other Pharmacovigilance Service Providers 12.21. ASEAN Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.21.1. Adverse Event Reporting Software 12.21.2. Drug Safety Audits Software 12.21.3. Issue Tracking Software 12.21.4. Fully Integrated Software 12.22. ASEAN Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.22.1. On-Premises 12.22.2. On-Demand/Cloud Based 12.23. ASEAN Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.23.1. Pharma and Biotech Companies 12.23.2. Contract Research Organizations (CROS) 12.23.3. Business Process Outsourcing (BPO) Firms 12.23.4. Other Pharmacovigilance Service Providers 12.24. Rest of Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 12.24.1. Adverse Event Reporting Software 12.24.2. Drug Safety Audits Software 12.24.3. Issue Tracking Software 12.24.4. Fully Integrated Software 12.25. Rest of Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 12.25.1. On-Premises 12.25.2. On-Demand/Cloud Based 12.26. Rest of Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 12.26.1. Pharma and Biotech Companies 12.26.2. Contract Research Organizations (CROS) 12.26.3. Business Process Outsourcing (BPO) Firms 12.26.4. Other Pharmacovigilance Service Providers 12.27. Asia Pacific Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 12.27.1. By Functionality 12.27.2. By Delivery Model 12.27.3. By End-User 12.28. PEST Analysis 13. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Overview 13.3. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 13.4. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 13.4.1. Adverse Event Reporting Software 13.4.2. Drug Safety Audits Software 13.4.3. Issue Tracking Software 13.4.4. Fully Integrated Software 13.5. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 13.6. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 13.6.1. On-Premises 13.6.2. On-Demand/Cloud Based 13.7. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 13.8. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.8.1. Pharma and Biotech Companies 13.8.2. Contract Research Organizations (CROS) 13.8.3. Business Process Outsourcing (BPO) Firms 13.8.4. Other Pharmacovigilance Service Providers 13.9. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 13.10. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Country 13.10.1. GCC, 2018–2026 13.10.2. South Africa, 2018–2026 13.10.3. Rest of Middle East & Africa, 2018–2026 13.11. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Analysis, by Country/ Sub-region 13.12. GCC Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 13.12.1. Adverse Event Reporting Software 13.12.2. Drug Safety Audits Software 13.12.3. Issue Tracking Software 13.12.4. Fully Integrated Software 13.13. GCC Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 13.13.1. On-Premises 13.13.2. On-Demand/Cloud Based 13.14. GCC Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.14.1. Pharma and Biotech Companies 13.14.2. Contract Research Organizations (CROS) 13.14.3. Business Process Outsourcing (BPO) Firms 13.14.4. Other Pharmacovigilance Service Providers 13.15. South Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 13.15.1. Adverse Event Reporting Software 13.15.2. Drug Safety Audits Software 13.15.3. Issue Tracking Software 13.15.4. Fully Integrated Software 13.16. South Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 13.16.1. On-Premises 13.16.2. On-Demand/Cloud Based 13.17. South Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.17.1. Pharma and Biotech Companies 13.17.2. Contract Research Organizations (CROS) 13.17.3. Business Process Outsourcing (BPO) Firms 13.17.4. Other Pharmacovigilance Service Providers 13.18. Rest of Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 13.18.1. Adverse Event Reporting Software 13.18.2. Drug Safety Audits Software 13.18.3. Issue Tracking Software 13.18.4. Fully Integrated Software 13.19. Rest of Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 13.19.1. On-Premises 13.19.2. On-Demand/Cloud Based 13.20. Rest of Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 13.20.1. Pharma and Biotech Companies 13.20.2. Contract Research Organizations (CROS) 13.20.3. Business Process Outsourcing (BPO) Firms 13.20.4. Other Pharmacovigilance Service Providers 13.21. Middle East & Africa Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 13.21.1. By Functionality 13.21.2. By Delivery Model 13.21.3. By End-User 13.22. PEST Analysis 14. Latin America Global Pharmacovigilance and Drug Safety Software Market Analysis 14.1. Key Findings 14.2. Latin America Global Pharmacovigilance and Drug Safety Software Market Overview 14.3. Latin America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Functionality 14.4. Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 14.4.1. Adverse Event Reporting Software 14.4.2. Drug Safety Audits Software 14.4.3. Issue Tracking Software 14.4.4. Fully Integrated Software 14.5. Latin America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Delivery Model 14.6. Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 14.6.1. On-Premises 14.6.2. On-Demand/Cloud Based 14.7. Latin America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by End-User 14.8. Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.8.1. Pharma and Biotech Companies 14.8.2. Contract Research Organizations (CROS) 14.8.3. Business Process Outsourcing (BPO) Firms 14.8.4. Other Pharmacovigilance Service Providers 14.9. Latin America Global Pharmacovigilance and Drug Safety Software Market Value Share Analysis, by Country 14.10. Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Country 14.10.1.1. Brazil, 2018–2026 14.10.1.2. Mexico, 2018–2026 14.10.1.3. Rest of Latin America, 2018–2026 14.11. Latin America Global Pharmacovigilance and Drug Safety Software Market Analysis, by Country/ Sub-region 14.12. Brazil Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 14.12.1. Adverse Event Reporting Software 14.12.2. Drug Safety Audits Software 14.12.3. Issue Tracking Software 14.12.4. Fully Integrated Software 14.13. Brazil Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 14.13.1. On-Premises 14.13.2. On-Demand/Cloud Based 14.14. Brazil Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.14.1. Pharma and Biotech Companies 14.14.2. Contract Research Organizations (CROS) 14.14.3. Business Process Outsourcing (BPO) Firms 14.14.4. Other Pharmacovigilance Service Providers 14.15. Mexico Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 14.15.1. Adverse Event Reporting Software 14.15.2. Drug Safety Audits Software 14.15.3. Issue Tracking Software 14.15.4. Fully Integrated Software 14.16. Mexico Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 14.16.1. On-Premises 14.16.2. On-Demand/Cloud Based 14.17. Mexico Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.17.1. Pharma and Biotech Companies 14.17.2. Contract Research Organizations (CROS) 14.17.3. Business Process Outsourcing (BPO) Firms 14.17.4. Other Pharmacovigilance Service Providers 14.18. Rest of Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Functionality 14.18.1. Adverse Event Reporting Software 14.18.2. Drug Safety Audits Software 14.18.3. Issue Tracking Software 14.18.4. Fully Integrated Software 14.19. Rest of Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by Delivery Model 14.19.1. On-Premises 14.19.2. On-Demand/Cloud Based 14.20. Rest of Latin America Global Pharmacovigilance and Drug Safety Software Market Forecast, by End-User 14.20.1. Pharma and Biotech Companies 14.20.2. Contract Research Organizations (CROS) 14.20.3. Business Process Outsourcing (BPO) Firms 14.20.4. Other Pharmacovigilance Service Providers 14.21. Latin America Global Pharmacovigilance and Drug Safety Software Market Attractiveness Analysis 14.21.1. By Functionality 14.21.2. By Delivery Model 14.21.3. By End-User 14.22. PEST Analysis 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.3. Company Profiles: Key Players 15.3.1. ArisGlobal 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Business Strategy 15.3.1.4. Recent Developments 15.3.1.5. Manufacturing Footprint 15.3.2. EXTEDO GmbH 15.3.3. Online Business Applications 15.3.4. Oracle Corporation 15.3.5. Sarjen Systems Pvt. Ltd 15.3.6. Sparta Systems, Inc. 15.3.7. United BioSource Corporation 15.3.8. United BioSource Corporation 15.3.9. Sparta Systems, Inc. 15.3.10. Oracle Corporation 15.3.11. Max Application 15.3.12. AB Cube 15.3.13. Relsys 15.3.14. UMBRA Global LLC